*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter - as a primary diagnosis code | T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 4.69 | |
| Readmission Rate (%) | 17.41 | |
| Unplanned Readmission Rate (%) | NA | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 101,548 | |
| Total Hospitalizations with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 44 | |
| DRG Share of Total Hospitalizations | 0.31 | |
| % of Total ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter in DRG | 57.14 | |
| Avg LOS at DRG | 4.68 | |
| Avg LOS with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 3.23 | |
| Readmission Rate at DRG | 32.74 | |
| Readmission Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | NA | |
| Unplanned Readmission Rate at DRG | 13.79 | |
| Unplanned Readmission Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | NA | |
| Total Medicare payments at DRG | $922,969,291 | |
| Total Medicare payments with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $368,366 | |
| Total Medicare payment per Day at DRG | $1,941 | |
| Total Medicare payment per Day with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $2,594 | |
| Total Medicare payment per Hospitalization at DRG | $9,089 | |
| Total Medicare payment per Hospitalization with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $8,372 | |
| Total Medicare Charges at DRG | $4,727,523,206 | |
| Total Medicare Charges with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $1,340,640 | |
| Avg Charges at DRG | $46,555 | |
| Avg Charges with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $30,469 | |
| Mortality Rate at DRG | 2.95 | |
| Mortality Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | NA | |
| SNF Discharge Rate at DRG | 13.87 | |
| SNF Discharge Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | NA | |
| Home Discharge Rate at DRG | 43.04 | |
| Home Discharge Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 63.64 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 379: G.I. HEMORRHAGE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 408,103 | ||||
| Total Hospitalizations with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 10,309 | ||||
| DRG Share of Total Hospitalizations | 1.24 | ||||
| % of Total ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter in DRG | 24.29 | ||||
| Avg LOS at DRG | 3.52 | ||||
| Avg LOS with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 3.13 | ||||
| Readmission Rate at DRG | 17.83 | ||||
| Readmission Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 11.81 | ||||
| Unplanned Readmission Rate at DRG | 13.81 | ||||
| Unplanned Readmission Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 9.05 | ||||
| Total Medicare payments at DRG | $2,416,862,532 | ||||
| Total Medicare payments with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $58,584,560 | ||||
| Total Medicare payment per Day at DRG | $1,682 | ||||
| Total Medicare payment per Day with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $1,818 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,922 | ||||
| Total Medicare payment per Hospitalization with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $5,683 | ||||
| Total Medicare Charges at DRG | $13,267,744,847 | ||||
| Total Medicare Charges with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $319,108,233 | ||||
| Avg Charges at DRG | $32,511 | ||||
| Avg Charges with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $30,954 | ||||
| Mortality Rate at DRG | 0.72 | ||||
| Mortality Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 0.37 | ||||
| SNF Discharge Rate at DRG | 14.1 | ||||
| SNF Discharge Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 9.55 | ||||
| Home Discharge Rate at DRG | 62.97 | ||||
| Home Discharge Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 72.81 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 384: UNCOMPLICATED PEPTIC ULCER WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 684: RENAL FAILURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,808,415 | ||||
| Total Hospitalizations with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 1,280 | ||||
| DRG Share of Total Hospitalizations | 5.5 | ||||
| % of Total ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter in DRG | 3.02 | ||||
| Avg LOS at DRG | 6.34 | ||||
| Avg LOS with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 6.92 | ||||
| Readmission Rate at DRG | 24.2 | ||||
| Readmission Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 21.77 | ||||
| Unplanned Readmission Rate at DRG | 16.78 | ||||
| Unplanned Readmission Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 13.54 | ||||
| Total Medicare payments at DRG | $21,288,214,047 | ||||
| Total Medicare payments with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $14,698,341 | ||||
| Total Medicare payment per Day at DRG | $1,857 | ||||
| Total Medicare payment per Day with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $1,660 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
| Total Medicare payment per Hospitalization with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $11,483 | ||||
| Total Medicare Charges at DRG | $107,155,481,388 | ||||
| Total Medicare Charges with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $82,203,412 | ||||
| Avg Charges at DRG | $59,254 | ||||
| Avg Charges with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $64,221 | ||||
| Mortality Rate at DRG | 12.11 | ||||
| Mortality Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 5.23 | ||||
| SNF Discharge Rate at DRG | 27.18 | ||||
| SNF Discharge Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 24.3 | ||||
| Home Discharge Rate at DRG | 25.81 | ||||
| Home Discharge Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 36.48 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 811: RED BLOOD CELL DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 327: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,522,684 | ||||
| Total Hospitalizations with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 656 | ||||
| DRG Share of Total Hospitalizations | 4.63 | ||||
| % of Total ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter in DRG | 1.55 | ||||
| Avg LOS at DRG | 2.52 | ||||
| Avg LOS with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 3.41 | ||||
| Readmission Rate at DRG | 9.03 | ||||
| Readmission Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 12.79 | ||||
| Unplanned Readmission Rate at DRG | 3.35 | ||||
| Unplanned Readmission Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 5.46 | ||||
| Total Medicare payments at DRG | $17,672,828,347 | ||||
| Total Medicare payments with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $7,996,275 | ||||
| Total Medicare payment per Day at DRG | $4,606 | ||||
| Total Medicare payment per Day with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $3,578 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,606 | ||||
| Total Medicare payment per Hospitalization with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $12,189 | ||||
| Total Medicare Charges at DRG | $91,836,200,128 | ||||
| Total Medicare Charges with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $44,854,994 | ||||
| Avg Charges at DRG | $60,312 | ||||
| Avg Charges with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $68,377 | ||||
| Mortality Rate at DRG | 0.05 | ||||
| Mortality Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 23.53 | ||||
| SNF Discharge Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 31.71 | ||||
| Home Discharge Rate at DRG | 30.67 | ||||
| Home Discharge Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 22.26 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 381: COMPLICATED PEPTIC ULCER WITH COMPLICATION OR COMORBIDITY (CC) | DRG 326: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 22,666 | ||||
| Total Hospitalizations with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 420 | ||||
| DRG Share of Total Hospitalizations | 0.07 | ||||
| % of Total ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter in DRG | 0.99 | ||||
| Avg LOS at DRG | 3.98 | ||||
| Avg LOS with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 3.52 | ||||
| Readmission Rate at DRG | 20.75 | ||||
| Readmission Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 13.02 | ||||
| Unplanned Readmission Rate at DRG | 15.25 | ||||
| Unplanned Readmission Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 9.83 | ||||
| Total Medicare payments at DRG | $150,069,407 | ||||
| Total Medicare payments with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $2,696,928 | ||||
| Total Medicare payment per Day at DRG | $1,665 | ||||
| Total Medicare payment per Day with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $1,826 | ||||
| Total Medicare payment per Hospitalization at DRG | $6,621 | ||||
| Total Medicare payment per Hospitalization with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $6,421 | ||||
| Total Medicare Charges at DRG | $841,069,885 | ||||
| Total Medicare Charges with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $14,307,283 | ||||
| Avg Charges at DRG | $37,107 | ||||
| Avg Charges with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | $34,065 | ||||
| Mortality Rate at DRG | 0.6 | ||||
| Mortality Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 17.03 | ||||
| SNF Discharge Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 10.24 | ||||
| Home Discharge Rate at DRG | 58.25 | ||||
| Home Discharge Rate with ICD T39395A - Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter | 71.19 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| RIVERSIDE METHODIST HOSPITAL | 3535 OLENTANGY RIVER RD | COLUMBUS | OH | 43214 | 177 |
| CHRISTIANA CARE WILMINGTON HOSPITAL | 501 W 14TH ST | WILMINGTON | DE | 19801 | 160 |
| NEW HANOVER REGIONAL MEDICAL CENTER | 2131 S 17TH ST | WILMINGTON | NC | 28401 | 142 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. SATISH K SONDHI | 250 S CRESCENT DR | MASON CITY | IA | 50401 | 26 |
| Dr. JOHN STEVEN MATHEWS | 151 MCGOWAN CT | HOT SPRINGS | AR | 71913 | 21 |
| Dr. RUCHIR P PATEL | 7333 NORTH FWY STE 401 | HOUSTON | TX | 77076 | 18 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. ZIAD SOUS | 1145 S UTICA AVE | TULSA | OK | 74104 | 28 |
| Dr. ALEXANDRE MAKARIAN | 1100 N KENTUCKY AVE | WEST PLAINS | MO | 65775 | 22 |
| Dr. RAJAT PRAKASH | 3050 COMMERCE DR | FORT GRATIOT | MI | 48059 | 18 |